Moser, Nicholas
Popovic, Milos R.
Kalsi-Ryan, Sukhvinder
Funding for this research was provided by:
mitacs
Article History
Received: 21 February 2024
Accepted: 31 May 2024
First Online: 10 July 2024
Declarations
:
: Ethics approval for this clinical trial has been granted by the University Health Network Research Ethics Board (#22-5560). All participants are required to provide both verbal and written informed consent before commencing any experimental procedures.
: Not applicable.
: Dr. Milos R. Popovic is co-founder, director, and shareholder in companies MyndTec Inc and ERNE Inc. He is also consultant for the company Fourier Intelligence. The other authors have no competing interests to disclose.